Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

MLTX · Insider trading · 13F holders · Congress trades

Moonlake Immunotherapeutics (MLTX)

Who is buying and selling MLTX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.

13F filers holding
19
Insider buys, 90 days
$0
Insider sales, 90 days
$0
Congress trades, 12 months
0

MLTX at a glance

  • No open-market insider purchases or sales of MLTX were filed in the last 90 days.
  • 19 13F filers hold MLTX among their 50 largest positions, worth $733.5M combined. The biggest bets by portfolio weight are Bvf Inc/il (8.0%), Lion Point Capital, LP (6.3%) and Great Point Partners LLC (3.9%). In their latest 13Fs, 2 managers opened a new position and 6 added to one.
  • No member of Congress has disclosed a trade in MLTX.

MLTX insider trading

No open-market insider purchases or sales of MLTX were filed in the last 90 days.

Who owns MLTX? Hedge funds and superinvestors

19 13F filers hold MLTX among their 50 largest positions, worth $733.5M combined. The biggest bets by portfolio weight are Bvf Inc/il (8.0%), Lion Point Capital, LP (6.3%) and Great Point Partners LLC (3.9%). In their latest 13Fs, 2 managers opened a new position and 6 added to one.

13F filers holding MLTX
Manager% of portfolioValueSharesLast quarter13F
Bvf Inc/ilInvestment manager8.0%$311.5M16,001,284+0.0% sharesQ2 2026
Deep Track Capital, LPHedge fund2.0%$136.3M6,999,025+9.2% sharesQ2 2026
Cormorant Asset Management, LPHedge fund3.2%$62.4M3,205,433-28.5% sharesQ2 2026
Logos Global Management LPHedge fund2.2%$52.1M2,675,000+78.3% sharesQ2 2026
Weiss Asset Management LPHedge fund0.7%$50.3M2,581,813+51.1% sharesQ2 2026
Mpm Bioimpact LLCHedge fund1.9%$31.3M1,606,967-11.3% sharesQ2 2026
Vivo Capital, LLCHedge fund2.5%$27.3M1,400,000+40.0% sharesQ2 2026
Great Point Partners LLCHedge fund3.9%$16.7M855,813+71.2% sharesQ2 2026
Trails Edge Capital Partners, LPHedge fund2.3%$14.6M750,000NewQ2 2026
Capricorn Fund Managers LtdHedge fund0.6%$7.3M374,866—Q2 2026
Boxer Capital Management, LLCHedge fund0.4%$5.4M275,000+0.0% sharesQ2 2026
Acuta Capital Partners, LLCHedge fund2.9%$4.2M215,652+12.5% sharesQ2 2026
HighVista Strategies LLCHedge fund0.8%$3.7M187,946-3.1% sharesQ2 2026
Kalehua Capital Management LLCHedge fund2.5%$3.4M175,734+0.0% sharesQ2 2026
Exome Asset Management LLCHedge fund2.0%$3.2M166,493-22.7% sharesQ2 2026
Monashee Investment Management LLCInstitutional asset manager2.7%$1.5M75,000NewQ2 2026
Lion Point Capital, LPHedge fund6.3%$1.3M67,500+0.0% sharesQ2 2026
Stonepine Capital Management, LLCHedge fund0.7%$974K50,000—Q2 2026
Crystal Cove Asset Management, LLCWealth manager0.2%$195K10,000+0.0% sharesQ2 2026

Each manager counts with its latest 13F (Q2 2026: 19). Screen MLTX in the grand portfolio →

MLTX stock trades by members of Congress

No member of Congress has disclosed a trade in MLTX.

MLTX questions and answers

Are insiders buying MLTX stock?

No open-market insider purchases or sales of MLTX were filed in the last 90 days.

Which hedge funds own MLTX?

19 13F filers hold MLTX among their 50 largest positions, worth $733.5M combined. The biggest bets by portfolio weight are Bvf Inc/il (8.0%), Lion Point Capital, LP (6.3%) and Great Point Partners LLC (3.9%). In their latest 13Fs, 2 managers opened a new position and 6 added to one.

Has Congress traded MLTX?

No member of Congress has disclosed a trade in MLTX.

Who is the largest holder of MLTX?

Among 13F filers, Bvf Inc/il reports the largest MLTX position, $311.5M (16,001,284 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Bvf Inc/il's: 8.0% of its portfolio.

Cite or share this

Free to use with a link back. The data updates every filing day.

Citation
Link